Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 23, Issue 1

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 23, Issue 1 (2014)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 23, Issue 1 (2014)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Volume 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases

Jerry R Colca, Steven P Tanis, William G McDonald & Rolf F Kletzien

Pages: 1-7

Published online: 27 Sep 2013

AbstractforInsulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases | Full Text | References | PDF (505.8 KB)

1715 Views
45 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Antigen-specific tolerization approaches in multiple sclerosis

Andreas Lutterotti & Roland Martin

Pages: 9-20

Published online: 23 Oct 2013

AbstractforAntigen-specific tolerization approaches in multiple sclerosis | Full Text | References | PDF (401 KB)

692 Views
30 CrossRef citations
0Altmetric

Review Article

New G-CSF agonists for neutropenia therapy

Jonathan Hoggatt PhD & Louis M Pelus PhD

Pages: 21-35

Published online: 27 Sep 2013

AbstractforNew G-CSF agonists for neutropenia therapy | Full Text | References | PDF (464.5 KB)

865 Views
21 CrossRef citations
0Altmetric

Review Article

Beyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer

Federica Tomao, Anselmo Papa, Luigi Rossi, Davide Caruso, Federica Zoratto, Pierluigi Benedetti Panici & Silverio Tomao

Pages: 37-53

Published online: 11 Oct 2013

AbstractforBeyond bevacizumab: investigating new angiogenesis inhibitors in ovarian cancer | Full Text | References | PDF (335.7 KB)

403 Views
12 CrossRef citations
0Altmetric

Review Article

Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs

Peter Norman MBA PhD

Pages: 55-66

Published online: 27 Sep 2013

AbstractforUpdate on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs | Full Text | References | PDF (472.8 KB)

1523 Views
37 CrossRef citations
0Altmetric

Review Article

Proteasome inhibitors: possible novel therapeutic strategy for ischemia–reperfusion injury?

Apostolos N Kandilis, Nikolaos P Karidis, Gregory Kouraklis, Efstratios Patsouris, Ioanna Vasileiou & Stamatios Theocharis MD PhD

Pages: 67-80

Published online: 14 Oct 2013

AbstractforProteasome inhibitors: possible novel therapeutic strategy for ischemia–reperfusion injury? | Full Text | References | PDF (353.5 KB)

220 Views
6 CrossRef citations
0Altmetric

Review Article

Rho-kinase inhibitors offer a new approach in the treatment of glaucoma

Pratap Challa & John J Arnold

Pages: 81-95

Published online: 07 Oct 2013

AbstractforRho-kinase inhibitors offer a new approach in the treatment of glaucoma | Full Text | References | PDF (465.8 KB)

611 Views
19 CrossRef citations
0Altmetric

Review Article

Investigational drugs for onychomycosis

Aditya K Gupta MD PhD FAAD FRCP(C) & Fiona C Simpson HBSc

Pages: 97-106

Published online: 26 Sep 2013

AbstractforInvestigational drugs for onychomycosis | Full Text | References | PDF (312.1 KB)

403 Views
21 CrossRef citations
0Altmetric

Drug Evaluations

BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy

Edward Faught

Pages: 107-113

Published online: 23 Oct 2013

Abstractfor BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy | Full Text | References | PDF (325.2 KB)

531 Views
32 CrossRef citations
0Altmetric

Sunitinib malate in the treatment of urothelial cancer

Francesc Pons & Joaquim Bellmunt

Pages: 115-124

Published online: 04 Nov 2013

Abstractfor Sunitinib malate in the treatment of urothelial cancer | Full Text | References | PDF (272.1 KB)

164 Views
4 CrossRef citations
0Altmetric

Development of mavoglurant and its potential for the treatment of fragile X syndrome

Baltazar Gomez-Mancilla MD PhD, Elizabeth Berry-Kravis MD PhD, Randi Hagerman MD, Florian von Raison MD, George Apostol MD MS, Mike Ufer MD PhD, Fabrizio Gasparini & Sébastien Jacquemont MD

Pages: 125-134

Published online: 20 Nov 2013

AbstractforDevelopment of mavoglurant and its potential for the treatment of fragile X syndrome | Full Text | References | PDF (363.5 KB)

499 Views
23 CrossRef citations
0Altmetric

Afatinib in the treatment of head and neck squamous cell carcinoma

Renata Ferrarotto MD & Kathryn A Gold MD

Pages: 135-143

Published online: 25 Nov 2013

Abstractfor Afatinib in the treatment of head and neck squamous cell carcinoma | Full Text | References | PDF (264.9 KB)

602 Views
18 CrossRef citations
0Altmetric

Research Article

Article

Page: i

Published online: 06 Dec 2013

60 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.23, Iss.1, 2014)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?